Answers are grounded in this paper and cite their sources.
The MGUS-like profile is a baseline-evaluable feature that identifies a subset of patients with distinct clinical behavior and may predict greater benefit from high-dose melphalan, due to the high rate of CR MRD-ve resulting in longer survival.
No takes yet. Share an insight, caveat, or question.
Puertas et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: